Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
90Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma
Blood (2011)
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • Katherine A. Guthrie, Fred Hutchinson Cancer Research Center
  • Joseph Rajendran, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • George Oliveira, University of Washington
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Manuela C. Matesan, University of Washington
  • Rainer F. Storb, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
July 28, 2011
DOI
10.1182/blood-2010-12-324392
Citation Information
Ajay K. Gopal, Katherine A. Guthrie, Joseph Rajendran, John M. Pagel, et al.. "90Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma" Blood Vol. 118 Iss. 4 (2011) p. 1132 - 1139
Available at: http://works.bepress.com/john-pagel/174/